Paper33174643
Facing multidrug-resistant pathogens in periprosthetic joint infections with self-administered outpatient parenteral antimicrobial therapy-A prospective cohort study.
Frieler S and 5 others. J Orthop Res, 2021. Cited by 14 papers, by iCite.
Cite this record
ConductScience Library. Facing multidrug-resistant pathogens in periprosthetic joint infections with self-administered outpatient parenteral antimicrobial therapy-A prospective cohort study. Papers, record 33174643. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33174643
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Facing multidrug-resistant pathogens in periprosthetic joint infections with self-administered outpatient parenteral antimicrobial therapy-A prospective cohort study.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Arthritis, Infectious | Major topic |
| Drug Resistance, Multiple, Bacterial | Major topic |
| Prosthesis-Related Infections | Major topic |
| Administration, Intravenous | |
| Aged | |
| Aged, 80 and over | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Prospective Studies | |
| Self Administration |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42353753 | Clinical Outcomes and Safety Profile of Vancomycin in Outpatient Parenteral Antimicrobial Therapy Services: A Systematic Review. | Antibiotics (Basel) | 2026 | https://conductscience.org/library/papers/42353753 | PubMed |
| 41799685 | Outpatient parenteral antimicrobial therapy delivery, readmission rates, and multidisciplinary teams: a scoping review of the impact of published quality indicators. | Antimicrob Steward Healthc Epidemiol | 2026 | https://conductscience.org/library/papers/41799685 | PubMed |
| 40400766 | Shoulder prosthetic joint infection due to Pseudomonas aeruginosa and carbapenem-resistant Acinetobacter baumannii treated with ciprofloxacin, minocycline and continuous infusion fosfomycin as OPAT regimen: a case report. | JAC Antimicrob Resist | 2025 | https://conductscience.org/library/papers/40400766 | PubMed |
| 40354030 | Clinical and patient-reported outcomes of self-administered outpatient parenteral antimicrobial treatment (S-OPAT): a scoping review. | Infection | 2025 | https://conductscience.org/library/papers/40354030 | PubMed |
| 38842523 | Current practices and challenges of outpatient parenteral antimicrobial therapy: a narrative review. | J Antimicrob Chemother | 2024 | https://conductscience.org/library/papers/38842523 | PubMed |
| 38478255 | Outpatient parenteral antimicrobial therapy (OPAT) in Germany: insights and clinical outcomes from the K-APAT cohort study. | Infection | 2024 | https://conductscience.org/library/papers/38478255 | PubMed |
| 38275315 | A Review of the Clinical Utilization of Oral Antibacterial Therapy in the Treatment of Bone Infections in Adults. | Antibiotics (Basel) | 2023 | https://conductscience.org/library/papers/38275315 | PubMed |
| 37283634 | Fosfomycin for Non-Urinary Tract Infections: a systematic review. | Infez Med | 2023 | https://conductscience.org/library/papers/37283634 | PubMed |
| 36656335 | [Resection arthroplasty and arthrodesis in revision shoulder arthroplasty]. | Orthopadie (Heidelb) | 2023 | https://conductscience.org/library/papers/36656335 | PubMed |
| 35192512 | Articular spacers in two-stage revision arthroplasty for prosthetic joint infection of the hip and the knee. | EFORT Open Rev | 2022 | https://conductscience.org/library/papers/35192512 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33174643
GET https://conductscience.org/api/papers/v1/33174643/authors